If you have been told you have a low ovarian reserve or that your body is a poor responder to IVF medication, you are not alone. These are common challenges for women trying to conceive later in life or after several failed fertility cycles.

The good news? A lower ovarian reserve doesn’t mean your chances are gone; it just means your ovaries may respond better to a gentler, more individualized approach. That’s where Mini IVF, also known as Minimal Stimulation IVF, comes in.

What Does “Low Ovarian Reserve” Mean?

Every woman is born with a finite number of eggs. Over time, that supply naturally declines.

When fertility testing shows low Anti-Müllerian Hormone (AMH) levels or elevated Follicle-Stimulating Hormone (FSH), it indicates fewer eggs are left in the ovaries – and that they may not respond strongly to conventional, high-dose fertility medication.

Women with low ovarian reserve often:

  • Are over age 38 (though age is not the only factor)
  • Produce fewer than 8 eggs in a stimulated IVF cycle
  • Have experienced poor embryo development or failed cycles despite high medication doses

In fertility terms, this is known as a “poor ovarian response.”

Why Mini IVF Can Be a Better Fit

Traditional IVF aims to collect as many eggs as possible through aggressive stimulation. But for women with low ovarian reserve, this approach can backfire: more medication does not always mean more eggs.

Mini IVF takes the opposite approach. It uses lower doses of medication, often a short course of Clomid or Letrozole, plus a few small gonadotropin injections, to gently stimulate the ovaries.

The goal is not quantity; it’s quality. By working with the body’s natural rhythm, Mini IVF helps produce a smaller number of higher-quality eggs that are more likely to fertilize and develop into healthy embryos.

Because medication doses and monitoring are reduced, Mini IVF also:

  • Lowers treatment cost by 30–50%
  • Reduces side effects like bloating, mood swings, and fatigue
  • Decreases the risk of ovarian hyperstimulation syndrome (OHSS)
  • Allows for faster recovery and shorter cycle times

What the Research Shows

Clinical studies continue to show that Mini IVF can match conventional IVF success rates for women with low ovarian reserve or poor responders when high-quality embryos are transferred.

For example, a 2020 meta-analysis in Reproductive BioMedicine Online found no difference in live-birth or ongoing pregnancy rates between mild (Mini) IVF and conventional IVF for poor responders. Notably,  the mild approach used less medication, lowered cost, and produced a similar proportion of high-quality embryos.

These findings reinforce that, for poor responders, gentler stimulation can yield equally strong outcomes.

Who Benefits Most from Mini IVF

Mini IVF is most effective for:

  • Women with low AMH or high FSH who don’t respond well to high-dose stimulation
  • Poor responders who have produced few eggs or poor-quality embryos in previous IVF cycles
  • Patients seeking a lower-cost, lower-stress alternative that still offers strong success rates

If you fall into one of these categories, Mini IVF may help you make the most of your remaining egg supply – without the strain or expense of repeated high-dose cycles.

Key Takeaways

Mini IVF is not a scaled-back version of fertility treatment – it’s a smarter, more tailored approach for women whose ovaries no longer respond to aggressive medication.

By focusing on quality, comfort, and cost-efficiency, Mini IVF gives poor responders and women with low ovarian reserve a renewed chance at pregnancy – without unnecessary stress on the body or wallet.

If you have struggled with high-dose IVF or been told you have a low ovarian reserve, a consultation about Mini IVF could help determine if this gentler protocol is right for you.